# Exploratory Clinical Trial of Oral Paclitaxel Plus Radiotherapy in Patients With Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma

> **NCT07435454** · PHASE2 · RECRUITING · sponsor: **Jiangsu Cancer Institute & Hospital** · enrollment: 22 (estimated)

## Conditions studied

- Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma

## Interventions

- **OTHER:** oral paclitaxel+radiotherapy

## Key facts

- **NCT ID:** NCT07435454
- **Lead sponsor:** Jiangsu Cancer Institute & Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-01
- **Primary completion:** 2026-12-01
- **Final completion:** 2027-12-01
- **Target enrollment:** 22 (ESTIMATED)
- **Last updated:** 2026-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07435454

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07435454, "Exploratory Clinical Trial of Oral Paclitaxel Plus Radiotherapy in Patients With Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07435454. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*